Having trouble accessing articles? Reset your cache.

FDA panel backs ceftaroline

FDA's Anti-Infective Drugs Advisory Committee was unanimous that ceftaroline from Forest Laboratories Inc. (NYSE:FRX) was a safe and effective treatment

Read the full 207 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE